The Target to Patient meeting takes place at the Wellcome Genome Campus in Hinxton, UK on May 8-10, 2022.
The meeting brings together scientific leaders to discuss and explore how advances in genomics, in vitro technologies, and data analysis are being used to identify new drug targets and improve clinical trials design.
If you are interested in learning more about Cellectricon’s drug discovery services please reach out to us.
Want to learn more?
If you would like to learn more about Cellectricon’s drug discovery services for pain and neurodegenerative disease research, you are very welcome to reach out and schedule a meeting with us.